For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Viela Bio, Inc.

USPTO Granted Patents = 9

EPO Patents = 1

Forward Citations = 11

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Katherine Ann Vousden (4 out of 6 patents)

Stacey Drabic (3 out of 10 patents)

Ronald Herbst (3 out of 14 patents)

4. Anthony Coyle (3 out of 20 patents)

5. Luba Grinberg (3 out of 3 patents)

6. Shabazz Novarra (3 out of 3 patents)

7. Vaheh Oganesyan (3 out of 6 patents)

8. David Kenneth Spencer (3 out of 3 patents)

9. Thomas Thisted (3 out of 7 patents)

10. Gary Patrick Sims (2 out of 2 patents)

11. Manuel Baca (2 out of 33 patents)

12. Julie Ann Douthwaite (2 out of 3 patents)

13. Miguel Angel Sanjuan (2 out of 2 patents)

14. Bo Chen (2 out of 4 patents)

15. Melissa Marie Damschroder (2 out of 26 patents)

9 patents: Sort by Forward Citations

1. 12648994 - METHODS OF TREATING IMMUNE-MEDIATED PULMONARY INJURY WITH AN ANTI-ILT7 ANTIBODY (2026-06-09),

2. 11746153 - Binding molecules specific for FcγRIIA and uses thereof (2023-09-05),

3. 11673950 - ILT7 binding molecules and methods of using the same (2023-06-13),

4. 11555062 - Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer (2023-01-17),

5. 11512127 - Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases (2022-11-29),

6. 11306145 - Binding molecules specific for FcγRIIA and uses thereof (2022-04-19),

7. 11104720 - Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit (2021-08-31),

8. 11072652 - ILT7 binding molecules and methods of using the same (2021-07-27),

9. 10000553 - CD40L-specific TN3-derived scaffolds and methods of use thereof (2018-06-19),

Viela Bio is a biotechnology company focused on developing and commercializing transformative medicines for severe autoimmune diseases. The company is dedicated to advancing its pipeline of novel therapies that have the potential to improve the lives of patients suffering from a range of debilitating conditions. Viela Bio's approach combines cutting-edge science with a deep understanding of autoimmune disease biology to create innovative solutions for patients in need.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

9 Patents

#50 in Gaithersburg, MD

#449 in Maryland

#32,549 in US

Gaithersburg, MD, United States of America

Viela Bio, Inc.

Forward Citations = 11

24 inventors:

Katherine Ann Vousden (4 out of 6 patents)

Stacey Drabic (3 out of 10 patents)

Ronald Herbst (3 out of 14 patents)

4. Anthony Coyle (3 out of 20 patents)

5. Luba Grinberg (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…